In order to improve the health of everyone in the world, we supply value-added products.

Since Taiko Pharmaceutical exported Seirogan to Hong Kong in 1954, the company has spared no efforts to promote its overseas business. When we are expanding our business to China, Taiwan, North America and Asia, we also plan various personnel training programs. As our overseas business keeps expanding, we established local companies in Taiwan and Hong Kong and an office in China in order to meet the local market needs. All these affiliates or branches are established to fulfill the needs of local customers and to develop and introduce products suitable for local markets.

Moreover, based on the government structure of different markets, we reinforce different forms of pharmaceutical research in order to create value-added products that can improve the health and environment of people in these markets and to increase the sales turnover of Taiko Pharmaceutical in overseas markets.